Literature DB >> 33947087

Rapid Spread of the SARS-CoV-2 Variant of Concern 202012/01 in Southern Italy (December 2020-March 2021).

Daniela Loconsole1, Francesca Centrone1, Caterina Morcavallo1, Silvia Campanella1, Anna Sallustio2, Marisa Accogli1, Francesca Fortunato3, Antonio Parisi4, Maria Chironna1.   

Abstract

Epidemiological and virological studies have revealed that SARS-CoV-2 variants of concern (VOCs) are emerging globally, including in Europe. The aim of this study was to evaluate the spread of B.1.1.7-lineage SARS-CoV-2 in southern Italy from December 2020-March 2021 through the detection of the S gene target failure (SGTF), which could be considered a robust proxy of VOC B.1.1.7. SGTF was assessed on 3075 samples from week 52/2020 to week 10/2021. A subset of positive samples identified in the Apulia region during the study period was subjected to whole-genome sequencing (WGS). A descriptive and statistical analysis of the demographic and clinical characteristics of cases according to SGTF status was performed. Overall, 20.2% of samples showed SGTF; 155 strains were confirmed as VOC 202012/01 by WGS. The proportion of SGTF-positive samples rapidly increased over time, reaching 69.2% in week 10/2021. SGTF-positive cases were more likely to be symptomatic and to result in hospitalization (p < 0.0001). Despite the implementation of large-scale non-pharmaceutical interventions (NPIs), such as the closure of schools and local lockdowns, a rapid spread of VOC 202012/01 was observed in southern Italy. Strengthened NPIs and rapid vaccine deployment, first among priority groups and then among the general population, are crucial both to contain the spread of VOC 202012/01 and to flatten the curve of the third wave.

Entities:  

Keywords:  COVID-19; Italy; VOC 202012/01-B.1.1.7 lineage SARS-CoV-2; surveillance; variants of concern

Mesh:

Year:  2021        PMID: 33947087     DOI: 10.3390/ijerph18094766

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  10 in total

1.  Characteristics of the First 284 Patients Infected with the SARS-CoV-2 Omicron BA.2 Subvariant at a Single Center in the Apulia Region of Italy, January-March 2022.

Authors:  Daniela Loconsole; Francesca Centrone; Anna Sallustio; Marisa Accogli; Daniele Casulli; Davide Sacco; Riccardo Zagaria; Caterina Morcavallo; Maria Chironna
Journal:  Vaccines (Basel)       Date:  2022-04-24

2.  Autochthonous Outbreak of SARS-CoV-2 Omicron Variant in Booster-Vaccinated (3 Doses) Healthcare Workers in Southern Italy: Just the Tip of the Iceberg?

Authors:  Daniela Loconsole; Lucia Bisceglia; Francesca Centrone; Anna Sallustio; Marisa Accogli; Lidia Dalfino; Nicola Brienza; Maria Chironna
Journal:  Vaccines (Basel)       Date:  2022-02-13

3.  The Disease Severity and Clinical Outcomes of the SARS-CoV-2 Variants of Concern.

Authors:  Lixin Lin; Ying Liu; Xiujuan Tang; Daihai He
Journal:  Front Public Health       Date:  2021-11-30

4.  Genomic monitoring of the SARS-CoV-2 B1.1.7 (WHO VOC Alpha) in the Sao Paulo state, Brazil.

Authors:  Svetoslav Nanev Slavov; Rafael Dos Santos Bezerra; Evandra Strazza Rodrigues; Elaine Vieira Santos; Joseane Serrano Borges; Débora Glenda Lima de la Roque; José Salvatore Leister Patané; Alex Ranieri Jerônimo Lima; Gabriela Ribeiro; Vincent Louis Viala; Loyze Paola Oliveira de Lima; Antonio Jorge Martins; Claudia Renata Dos Santos Barros; Elaine Cristina Marqueze; Jardelina de Souza Todão Bernardino; Debora Botequio Moretti; Ricardo Augusto Brassaloti; Raquel de Lello Rocha Campos Cassano; Pilar Drummond Sampaio Corrêa Mariani; João Paulo Kitajima; Bibiana Santos; Patricia Akemi Assato; Felipe Allan da Silva da Costa; Mirele Daiana Poleti; Jessika Cristina Chagas Lesbon; Elisangela Chicaroni Mattos; Cecilia Artico Banho; Lívia Sacchetto; Marília Mazzi Moraes; Rejane Maria Tommasini Grotto; Jayme A Souza-Neto; Marta Giovanetti; Luiz Carlos Junior de Alcantara; Maurício Lacerda Nogueira; Heidge Fukumasu; Luiz Lehmann Coutinho; Rodrigo Tocantins Calado; Raul Machado Neto; Dimas Tadeu Covas; Sandra Coccuzzo Sampaio; Maria Carolina Elias; Simone Kashima
Journal:  Virus Res       Date:  2021-11-27       Impact factor: 3.303

5.  Local occurrence and fast spread of B.1.1.7 lineage: A glimpse into Friuli Venezia Giulia.

Authors:  Catia Mio; Chiara Dal Secco; Stefania Marzinotto; Claudio Bruno; Santa Pimpo; Elena Betto; Martina Bertoni; Corrado Pipan; Emanuela Sozio; Carlo Tascini; Giuseppe Damante; Francesco Curcio
Journal:  PLoS One       Date:  2021-12-14       Impact factor: 3.240

Review 6.  Health system impacts of SARS-CoV - 2 variants of concern: a rapid review.

Authors:  Justine Dol; Leah Boulos; Mari Somerville; Lynora Saxinger; Alexander Doroshenko; Stephanie Hastings; Bearach Reynolds; Allyson Gallant; Hwayeon Danielle Shin; Helen Wong; Daniel Crowther; Marilyn Macdonald; Ruth Martin-Misener; Holly McCulloch; Andrea C Tricco; Janet A Curran
Journal:  BMC Health Serv Res       Date:  2022-04-23       Impact factor: 2.908

7.  Analysis of 256 pediatric oral and maxillofacial emergency in-patients during the outbreak of COVID-19.

Authors:  Xiao-Juan Fu; Wan-Shan Li; Li Xiang; Li-Shu Liao
Journal:  Dent Traumatol       Date:  2022-05-23       Impact factor: 3.328

8.  Excess Mortality on Italian Small Islands during the SARS-CoV-2 Pandemic: An Ecological Study.

Authors:  Matteo Riccò; Pietro Ferraro; Simona Peruzzi; Alessandro Zaniboni; Elia Satta; Silvia Ranzieri
Journal:  Infect Dis Rep       Date:  2022-05-26

9.  The non-pharmaceutical interventions may affect the advantage in transmission of mutated variants during epidemics: A conceptual model for COVID-19.

Authors:  Shi Zhao; Kai Wang; Marc K C Chong; Salihu S Musa; Mu He; Lefei Han; Daihai He; Maggie H Wang
Journal:  J Theor Biol       Date:  2022-03-21       Impact factor: 2.405

10.  Case Report: Discovery a Novel SARS-CoV-2 Variant in a Six-Months Long-Term Swab Positive Female Suffering From Non-Hodgkin Lymphoma.

Authors:  Ettore Capoluongo; Carmela Nardelli; Maria Valeria Esposito; Antonio Riccardo Buonomo; Monica Gelzo; Biagio Pinchera; Emanuela Zappulo; Giulio Viceconte; Giuseppe Portella; Mario Setaro; Ivan Gentile; Giuseppe Castaldo
Journal:  Front Oncol       Date:  2021-07-20       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.